Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 17 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) seeks label expansion from the FDA for its COVID-19 vaccine as a booster dose in...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 month agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 1 week agoNovavax stock zipped higher Thursday — and then gave it all up — after the Food and Drug...
Novavax (NVAX) Up 8% on FDA Nod for Updated COVID Booster Jab
Zacks via Yahoo Finance· 8 months agoNovavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12...
Is It Too Late to Buy Novavax Stock?
Motley Fool· 2 years agoBiotech company Novavax (NASDAQ: NVAX) has had a terrible year on the stock market, with its shares down by 86% year to date. The company does still face...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 1 month agoFor Immediate Release Chicago, IL – May 17, 2024 – Zacks.com announces the list of stocks featured...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
Zacks via Yahoo Finance· 7 months agoNovavax (NVAX) reports better-than-expected third-quarter results, with earnings and revenues...
FDA authorizes Novavax’s COVID-19 vaccine
The Today Show via AOL· 2 years agoThe Food and Drug Administration on Wednesday authorized Novavax’s protein-based COVID-19 vaccine for adults, providing Americans with an alternative to...